Jason Casarella imagines an R&D ecosystem where barriers and labels were eliminated and we could all work together as one community. He also shares the importance of learning every day, and how even failure in clinical research provides valuable information and knowledge … Read More »

Peyton Howell talks about what it would be like if we focused on bringing new treatments to patients using new, daring, and bold ideas. Filmed at the 2019 DIA Annual Conference in San Diego, CA.

Craig Lipset discusses his career highlights working on the clinical research service provider side as well as within large pharma, and how the industry can evolve and raise the bar in clinical research using new technologies and processes. Filmed at the 2019 DIA Annual Conf … Read More »

Sheila Mahoney-Jewels discusses her “Imagine if” scenario about a single place to find the right independent consultant who can be onboarded immediately for a specific amount of time over the course of a project. Filmed at the 2019 DIA Annual Conference in San Diego, CA.

Bruce Hellman imagines what would be possible if every person was a happily engaged research participant. Filmed at the 2019 DIA Annual Conference in San Diego, CA.

Andrew Schachter explains how sponsors can us technology to achieve trial objectives more quickly and easily even as clinical research becomes increasingly complex and as FDA regulations demand more accountability.

Marc Hoffman and Steve Clemons discuss the prevalence of COPD as the third-leading cause of death and how their two companies are collaborating to bring new biomarkers to sponsors and CROs to address this health crisis.

Tanya du Plessis discusses why the increased adoption of new solutions, including medical and consumer-grade technologies, changed data collection / management processes and the role of data managers.

Dr. MaryAnne Rizk discusses one of the hottest topics of the moment: the digital transformation of R&D. She explains how an end-to-end patient-centric cloud platform can provide the needed orchestration.

Joel Selzer discusses his company’s unique approach to measuring and analyzing behavioral insights from clinicians based on their interactions with educational and training content.

Eleanor Doyle talks about the evolution of FSP (functional service outsourcing) and how Syneos Health’s FSP 360 model is driving speed, quality, and efficiencies for customers.

Joe Ehrline talks about the opportunities and benefits that life-science companies can gain by effectively employing data analytics as part of a comprehensive strategy to accelerate drug development.

Bruce Palsulich discusses the impact AI will have on pharmacovigilance as well as other aspects of clinical trials and the industry at large.

Josh Rose discusses the coming of age of virtual trials and what sponsors need to know as they strategically evaluate this clinical model.

Dr. Deieso and Ms. Williams discuss patient centricity in clinical development and ways to improve the patient experience.

Wenda Brennan discusses important areas in adverse event reporting, and trends in pharmacovigilance.

Cat Hall discusses the next priorities for technology advancement in helping to manage clinical trials and what future customer needs will need to be met.

Raj Indupuri of eClinical Solutions talks about the need for companies to transform their processes and adopt digital clinical capabilities and how to overcome current obstacles to achieve better outcomes.

Karin Beckstrom discusses the opportunities that virtual trials can bring to the clinical trial ecosystem and to patients as well.

Mike Nolte talks about Signant’s new brand and the importance of bringing empathy into clinical trials.

Evgenia Mikhalchuk and Yvonne Lungershausen discuss the best practices for selecting the right clinical software provider and the benefits that a solid partnership provide to both entities.

Jason Casarella talks about why it’s important for companies to embrace E6 (R2), which provides a unified standard for the European Union, Japan, and the United States to facilitate the mutual acceptance of clinical data by the regulatory authorities in these jurisdictions.

Larissa Comis discusses How Cognizant Shared Investigator Platform is reducing the administrative burden on sites and why organizational change management is so important for success.

Dr. Michelle Longmire, CEO of Medable, talks about the value of eCOA and why it’s important to integrate data to improve the patient experience as part of participating in a clinical trial.

Executives reflect on the major shifts in the industry in the last 15 years and the evolving market dynamics that will impact global communication. You may also read the Executive Perspective article in the March issue of PharmaVOICE, using the link below.

Enjoy the Executive Forum.

Enjoy this visual recap of the 2018 PharmaVOICE 100 Celebration. Dozens of photos, video clips, and interviews showcase the amazing talent in our industry. This year’s core topic was Transformation.

This video explains what the PharmaVOICE Healthy Opinions webcast program is all about.

This white board “Explainer” video describes how you can re-purpose one piece of content for numerous other uses. PharmaVOICE has the expertise and knowledge to help you.

Dr. Deieso and Ms. Johnston discuss how Precision Medicine is impacting clinical trials, the opportunities provided by Precision Medicine, their partnership with Informed DNA, and the evolution of the Center for Genetics and Precision Medicine in Clinical Trials.

Mr. Alasso discusses the biggest challenges for sponsors and CROs in exploiting new technology in clinical research, enhancing the patient experience, the impact of technology on clinical trials in the next 3-5 years, and the biggest trend seen at DIA.

Todd Phillips talks about the importance or Patient-reported Outcomes (PROs), therapeutic areas using PROs, FDA guidances on PROs, and how pharma can incorporate PROs into their development programs.

Ms. Verst discusses how IQVIA addresses pain points in clinical research, using Real-world Data, advanced analytics, and machine learning, how technology enables collaboration, and how rare disease is driving productivity in clinical trials.

Dr. Stemhagen discusses using a Real-world Evidence strategy in clinical development, the practical applications of RWE, the long-term results of RWE, and trends seen while at DIA.

Mr. McGrath discusses MRN’s growth in the industry due to a patient-centric approach to recruitment and retention, the emergence of virtual trials, the inherent challenges of patient recruitment, and their partnership with Patient Primary to provide a patient travel support … Read More »

Ms. Kapoor talks about Cognizant’s Shared Investigator Platform, how it ties in with TransCelerate members, the qualitative and quantitative benefits of sponsors and sites using the platform, and interesting trends seen while at DIA.

Mr. Kalim discusses their two major acquisitions, their Smarter Testing for Oncology services, the ACM rebranding, and what they looked for at DIA this year.

Ms. Kent discusses the role of technology in the life-sciences, employing patient-centric clinical trials, and mentoring women in the industry.

Ms. Dilworth discusses the key challenges in operationalizing rare disease trials, the most exciting trends in rare disease trials, and what drives her to work in the rare disease space.

Mr. Damji discusses exciting trends in clinical trials, how AI and Natural Language Understanding will impact drug development, and optimizing the clinical journey using validated cloud-based solutions.

Dr. Morimoto discusses scientific breakthroughs and their impact on drug development efforts, expertise in vaccine research, and using biomarkers in clinical research.

Dr. Li talks about supporting the Life Sciences industry, the clinical trials ecosystem, and leveraging Real World Data in clinical research.

Mr. Benton discusses the evolution of the CRO industry, the sustainability of the current M&A model, what sponsors should look for in a CRO partner, how they maintain their company culture, and their vision for the future.

Mr. Kleger discusses alleviating the technology burden on clinical trial sites, the future of clinical trials, and technology trends and strategies for clinical research.

Mr. Monteleone discusses challenges CROs face working with sponsors, the importance of focusing on regulatory and strategic development issues, opportunities for small/mid-sized CROs, critical aspects of a good partnership, and understanding the dynamic changes in technology … Read More »

Mr. Duffy discusses trending skills in the life sciences industry, the gig economy, and attracting the best and brightest employees.

Mr. Casarella discusses why large clinical development service providers are slow to adapt to changes in technology, the impact of ICH E6(R2), optimal strategies for talent acquisition, and studies for oncology and rare diseases.

Mr. Hayashi discusses LabConnect’s collaboration with Symphony Clinical Research, hot topics at DIA, and technology as an industry connector. Mr. Hayhew discusses trends and issues related to PBMC isolation within clinical trials.

This is a PharmaVOICE-exclusive PodcastPlus version of the original audio podcast. It is enhanced with visuals to provide additional content. Advertising agencies have always been known by their ability to create amazingly creative campaigns. Its how they’ve built reputation … Read More »

Abhishek Shankar discusses the value of patient-centricity and and how the cloud is transforming operations in the life-sciences industry.